By: Don Miller
NextCure, Inc. (NASDAQ:NXTC – Get Free Report) major shareholder Adar1 Capital Management, Llc purchased 3,553 shares of the firm’s stock in a transaction on Tuesday, October 27th. The stock was acquired at an average price of $5.10 per share, for a total transaction of $18,120.30. Following the completion of the transaction, the insider directly owned […]